Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Greenwood Genetic Center Diagnostic Laboratories, |
RCV001814814 | SCV002061645 | likely pathogenic | Hypomyelinating leukodystrophy 10 | 2021-10-29 | criteria provided, single submitter | clinical testing | PVS1, PM2 |
Laboratorio de Genetica e Diagnostico Molecular, |
RCV001814814 | SCV003808076 | likely pathogenic | Hypomyelinating leukodystrophy 10 | 2023-01-20 | criteria provided, single submitter | clinical testing | ACMG classification criteria: PVS1 very strong, PM2 supporting |
Labcorp Genetics |
RCV005095231 | SCV005818644 | pathogenic | not provided | 2024-10-03 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Gln226*) in the PYCR2 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in PYCR2 are known to be pathogenic (PMID: 25865492, 27860360). This variant is present in population databases (rs201784173, gnomAD 0.02%). This variant has not been reported in the literature in individuals affected with PYCR2-related conditions. ClinVar contains an entry for this variant (Variation ID: 1334633). For these reasons, this variant has been classified as Pathogenic. |